The University of Oxford spinout has filed for an $86.25m initial public offering in the US just three years after being founded.

Initial public offerings have been a rare sight in the university venturing world so far this year. In fact, not much has happened since G1 Therapeutics, an oncology therapy developer spun out from North Carolina University, filed for an $115m IPO back in April. Nightstarx, a spinout from University of Oxford that is working on…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.